奎尔素作为乳腺癌的多向治疗剂:分子点和治疗潜力
Ahmed Hjazi1, Sumaya Nadhim Mohammed2, Munthar Kadhim Abosaoda3
1Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, 11942, Al-Kharj, Saudi Arabia.
Medical oncology (Northwood, London, England)
|July 22, 2025
概括
昆素是一种植物性化合物,通过向关键分子通路,在乳腺癌治疗中表现有前途. 它可以提高化疗的有效性,克服耐药性,表明其作为组合治疗剂的潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 乳腺癌存在重大挑战,包括药物耐药性,毒性和复发.
- 植物衍生化合物正在被探索为替代治疗剂.
- 奎尔赛丁是一种食类黄醇,已证明具有抗癌性质.
研究的目的:
- 对乳腺癌中奎尔丁的分子机制进行审查.
- 探索奎尔丁在克服耐药性和增强化疗方面的潜力.
- 要突出奎尔塞丁作为一种潜在的组合疗法剂的作用.
主要方法:
- 关于奎尔塞丁对乳腺癌的影响现有证据的文献综述.
- 分析素调节的分子通路,包括PI3K/Akt/mTOR,Wnt/β-catenin,JAK/STAT,AMPK和非编码RNA.
- 机械学理解和翻译适用性的综合.
主要成果:
- 奎尔塞丁调节多种瘤信号通路,对乳腺癌进展至关重要.
- 有证据表明,奎尔丁可以增强传统化疗的疗效.
- 奎尔丁显示出抑制乳腺癌多药耐药性的潜力.
结论:
- 奎尔在乳腺癌病理生物学中表现出性作用.
- 奎尔素作为乳腺癌治疗的补充剂具有治疗潜力.
- 对基于奎尔丁的组合疗法的进一步研究是有必要的.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


